Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Teva Pharmaceutical Industries (NY: TEVA)
39.49 USD  +0.14 (+0.36%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote Chart Options News SEC Filings
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 3,557,014
Open 38.84
Bid (Size) 39.49 (1200)
Ask (Size) 39.50 (1000)
Prev. Close 39.35
Today's Range 38.80 - 39.77
52wk Range 36.63 - 42.83
Shares Outstanding 852,000,000
Dividend Yield 2.46%
Top News
More News
Pfizer halts study of lymphoma drug unlikely to help survival
May 20, 2013
May 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive... Read More
category companyNews
from Reuters: Company News
Pharma M&A – Actavis to Acquire Warner Chilcott
May 20, 2013
On Monday, generic drug maker Actavis Inc. (NYSE: ACT ) announced plans to purchase specialty pharmaceutical company Warner Chilcott (NASDAQ: WCRX ) in an all-stock deal valued around $8.5 billion.... Read More
category Benzinga , Global , VRX , and 8 more.
from Latest Articles from Benzinga.com

More News
Read More
UPDATE 3-Actavis to buy Warner Chilcott in $5 billion stock deal
May 20, 2013
category companyNews
from Reuters: Company News
Teva Pharmaceutical Industries Earnings Hindsight: Up 6.4% in Last 18 Days (TEVA)
May 20, 2013
from Comtex SmarTrend® News Briefs
Options Alert for Teva Pharmaceutical Industries (TEVA)
May 15, 2013
from AVAFIN
Natural Products Ingredient Innovator Generating Interest Among Investors Institutions and Industry
May 14, 2013
from ACCESSWIRE
Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 14, 2013
from Business Wire News Releases
Israel Joins Rate Cut Club; ETF Doesn't Care And Falls
May 13, 2013
category Specialty ETFs , Benzinga , Global , and 12 more.
from Latest Articles from Benzinga.com
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief Scientist
May 13, 2013
from Business Wire News Releases
Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert
May 13, 2013
category Pharmaceuticals
from Trefis
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here